Although the hazard ratio for MACE (HR 1.33; 95% CI, 0.91–1.94) did not reach statistical significance, the results led to a class-wide update in product labeling and the issuance of black-box warnings for all JAK inhibitors.
← all excerpts
The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review.
1
—
—